Please contact our sales representative to learn more information about this reagents.
Background
Placulumab is a human monoclonal antibody designed for the treatment of inflammatory diseases. This drug was developed by Teva Pharmaceutical Industries, Inc. As of 2012, development of placulumab has been discontinued.